APA-viite

Arcangeli, S., Falcone, L., Camisa, B., De Girardi, F., Biondi, M., Giglio, F., . . . Casucci, M. (2020). Next-Generation Manufacturing Protocols Enriching T(SCM) CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients. Front Immunol.

Chicago-tyylinen lähdeviittaus

Arcangeli, Silvia, et al. "Next-Generation Manufacturing Protocols Enriching T(SCM) CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients." Front Immunol 2020.

MLA-viite

Arcangeli, Silvia, et al. "Next-Generation Manufacturing Protocols Enriching T(SCM) CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients." Front Immunol 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.